Clinical Trial Update: Efficacy and Safety of Tislelizumab and Nab-paclitaxel Combined With Low-dose Radiotherapy in Patients With Stage IVb Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 study assessing the efficacy and safety of tislelizumab plus nab-paclitaxel with low-dose radiotherapy in stage IVb esophageal squamous cell carcinoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: The First Affiliated Hospital of Xinxiang Medical College | Conditions: ESCC | Phase 2 | Status: UNKNOWN